Literature DB >> 17259492

The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes.

Louis Monnier1, Claude Colette, Gareth J Dunseath, David R Owens.   

Abstract

OBJECTIVE: The aim of the study was to determine whether the loss of fasting and postprandial glycemic control occurs in parallel or sequentially in the evolution of type 2 diabetes. RESEARCH DESIGN AND METHODS: In 130 type 2 diabetic patients, 24-h glucose profiles were obtained using a continuous glucose monitoring system. The individuals with type 2 diabetes were divided into five groups according to A1C levels: 1 (<6.5%, n = 30), 2 (6.5-6.9%, n = 17), 3 (7-7.9%, n = 32), 4 (8-8.9%, n = 25), and 5 (> or =9%, n = 26). The glucose profiles between the groups were compared. The overall glucose concentrations for the diurnal, nocturnal, and morning periods, which represent the postprandial, fasting, and the dawn phenomenon states, respectively, were also compared.
RESULTS: Glucose concentrations increased steadily from group 1 to 5 in a stepwise manner. The initial differences in mean glucose concentrations reaching statistical significance occurred 1) between groups 1 and 2 (6.4 vs. 7.7 mmol/l, P = 0.0004) for daytime postprandial periods, followed by differences; 2) between groups 2 and 3 (7.5 vs. 9.3 mmol/l, P = 0.0003) for the morning periods (dawn phenomenon); and finally 3) between groups 3 and 4 (6.3 vs. 8.4 mmol/l, P < 0.0001) for nocturnal fasting periods.
CONCLUSIONS: The deterioration of glucose homeostasis in individuals with type 2 diabetes progressed from postprandial to fasting hyperglycemia following a three-step process. The first step related to the three diurnal postmeal periods considered as a whole, the second step occurred during the morning period, and the third and final step corresponded to sustained hyperglycemia over the nocturnal fasting periods. Such a description of the key stages in the evolution of type 2 diabetes may be of interest for implementing antidiabetes treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17259492     DOI: 10.2337/dc06-1612

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  117 in total

1.  Glucose information for tight glycemic control: different methods with different challenges.

Authors:  Christian Weber; Kurt Neeser
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

Review 2.  Impact of postprandial glycaemia on health and prevention of disease.

Authors:  E E Blaak; J-M Antoine; D Benton; I Björck; L Bozzetto; F Brouns; M Diamant; L Dye; T Hulshof; J J Holst; D J Lamport; M Laville; C L Lawton; A Meheust; A Nilson; S Normand; A A Rivellese; S Theis; S S Torekov; S Vinoy
Journal:  Obes Rev       Date:  2012-07-11       Impact factor: 9.213

Review 3.  Near normal HbA1c with stable glucose homeostasis: the ultimate target/aim of diabetes therapy.

Authors:  L Monnier; C Colette; S Dejager; D R Owens
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

4.  Pathogenesis of selective insulin resistance in isolated hepatocytes.

Authors:  Joshua R Cook; Fanny Langlet; Yoshiaki Kido; Domenico Accili
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

5.  6(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG) applications and beyond, April 25-27, 2013, Riga, Latvia.

Authors:  Aus Alzaid; Christof Schlaeger; Rolf Hinzmann
Journal:  Diabetes Technol Ther       Date:  2013-09-28       Impact factor: 6.118

Review 6.  What are the best options for controlling prandial glycemia?

Authors:  Stephen Clement
Journal:  Curr Diab Rep       Date:  2009-10       Impact factor: 4.810

Review 7.  Risk of postprandial insulin resistance: the liver/vagus rapport.

Authors:  Maria Paula Macedo; Inês S Lima; Joana M Gaspar; Ricardo A Afonso; Rita S Patarrão; Young-Bum Kim; Rogério T Ribeiro
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

8.  Development and preliminary evaluation of a simulation-based diabetes education module.

Authors:  Bryan Gibson; Charlene Weir
Journal:  AMIA Annu Symp Proc       Date:  2010-11-13

Review 9.  Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.

Authors:  D Giugliano; A Ceriello; E Razzoli; K Esposito
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

10.  Postprandial blood glucose response to a standard test meal in insulin-requiring patients with diabetes treated with insulin lispro mix 50 or human insulin mix 50.

Authors:  Y Gao; G Li; Y Li; X Guo; G Yuan; Q Gong; L Yan; Y Zheng; J Zhang
Journal:  Int J Clin Pract       Date:  2008-07-24       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.